"The U.S. Food and Drug Administration today approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and vomiting.
Diclegis is a delayed-release tablet intended for women who have"...
- Patient Information:
Details with Side Effects
- Hypersensitivity (including anaphylaxis and angioedema) to HEMABATE Sterile Solution [see ADVERSE REACTIONS, Post-marketing Experience]
- Acute pelvic inflammatory disease
- Patients with active cardiac, pulmonary, renal or hepatic disease
Last reviewed on RxList: 3/3/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Hemabate Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Parenting and Pregnancy
Get tips for baby and you.